We are live on ! Find out more
IART icon

Integra LifeSciences

278 hedge funds and large institutions have $4.71B invested in Integra LifeSciences in 2022 Q1 according to their latest regulatory filings, with 29 funds opening new positions, 112 increasing their positions, 92 reducing their positions, and 24 closing their positions.

New
Increased
Maintained
Reduced
Closed

28% more call options, than puts

Call options by funds: $10.2M | Put options by funds: $7.96M

22% more repeat investments, than reductions

Existing positions increased: 112 | Existing positions reduced: 92

21% more first-time investments, than exits

New positions opened: 29 | Existing positions closed: 24

0% more funds holding

Funds holding: 277278 (+1)

1.7% less ownership

Funds ownership: 91.4%89.7% (-1.7%)

9% less capital invested

Capital invested by funds: $5.16B → $4.71B (-$449M)

50% less funds holding in top 10

Funds holding in top 10: 21 (-1)

Holders
278
Holders Change
+1
Holders Change %
+0.36%
% of All Funds
4.38%
Holding in Top 10
1
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-50%
% of All Funds
0.02%
New
29
Increased
112
Reduced
92
Closed
24
Calls
$10.2M
Puts
$7.96M
Net Calls
+$2.23M
Net Calls Change
+$12.9M
Name Holding Trade Value Shares
Change
Change in
Stake
Prudential Financial
101
Prudential Financial
New Jersey
$2.23M -$351K -5,331 -13%
ACM
102
AlphaCrest Capital Management
New York
$2.21M +$1.61M +24,465 +245%
OQS
103
Occudo Quantitative Strategies
Florida
$2.13M +$135K +2,047 +7%
ETC
104
Exchange Traded Concepts
Oklahoma
$2.12M -$836K -12,693 -28%
VRS
105
Virginia Retirement Systems
Virginia
$2.05M
Jane Street
106
Jane Street
New York
$2.05M -$133K -2,025 -6%
T. Rowe Price Associates
107
T. Rowe Price Associates
Maryland
$1.93M +$113K +1,712 +6%
DT
108
Diversified Trust
Tennessee
$1.87M +$160K +2,425 +9%
Barclays
109
Barclays
United Kingdom
$1.86M +$595K +9,040 +45%
State of Tennessee, Department of Treasury
110
State of Tennessee, Department of Treasury
Tennessee
$1.85M -$1.32M -20,000 -41%
Victory Capital Management
111
Victory Capital Management
Texas
$1.82M +$513K +7,788 +35%
ECM
112
ExodusPoint Capital Management
New York
$1.82M +$1.3M +19,684 +226%
GIA
113
GHP Investment Advisors
Colorado
$1.82M +$1.86M +28,275 New
DTL
114
Dynamic Technology Lab
Singapore
$1.78M -$442K -6,718 -19%
COPPSERS
115
Commonwealth of Pennsylvania Public School Employees Retirement System
Pennsylvania
$1.72M +$168K +2,546 +11%
Treasurer of the State of North Carolina
116
Treasurer of the State of North Carolina
North Carolina
$1.71M +$27.9K +423 +2%
SFI
117
Susquehanna Fundamental Investments
Pennsylvania
$1.7M +$1.74M +26,379 New
Ensign Peak Advisors
118
Ensign Peak Advisors
Utah
$1.64M
Nisa Investment Advisors
119
Nisa Investment Advisors
Missouri
$1.58M
OPERF
120
Oregon Public Employees Retirement Fund
Oregon
$1.5M -$16.5K -251 -1%
PNC Financial Services Group
121
PNC Financial Services Group
Pennsylvania
$1.5M -$247K -3,755 -14%
Bank of Montreal
122
Bank of Montreal
Ontario, Canada
$1.48M -$63.7K -967 -4%
LPL Financial
123
LPL Financial
California
$1.44M +$252K +3,821 +21%
FDCDDQ
124
Federation des caisses Desjardins du Quebec
Quebec, Canada
$1.38M
TCM
125
Tandem Capital Management
New Jersey
$1.33M +$1.45M +21,978 New

IART Hedge Fund Activity: Q1 2022 in Review

278 of the 6,340 institutional investors tracked by Wall St. Rank reported a position in Integra LifeSciences (IART) for Q1 2022, worth a combined $4.71B — down 8.7% from $5.16B a quarter earlier.

Buyers outnumbered sellers: 29 funds opened new IART positions and 24 closed out — a net gain of 5 holders — while 112 added to existing stakes and 92 trimmed.

The largest buyer was Two Sigma Investments, opening a new position worth an estimated $18.6M. The largest seller was Wellington Management Group, cutting an estimated $153M.

  • 278 institutional investors held Integra LifeSciences (IART) as of Q1 2022, up from 277 in Q4 2021.
  • Funds reported $4.71B of Integra LifeSciences stock for Q1 2022, down 8.7% quarter-over-quarter.
  • 29 funds opened new Integra LifeSciences positions in Q1 2022 and 24 closed out, a net change of +5 holders.
  • The largest Integra LifeSciences buyer in Q1 2022 was Two Sigma Investments, an estimated $18.6M added.
  • The largest Integra LifeSciences seller in Q1 2022 was Wellington Management Group, an estimated $153M sold.

Based on aggregated 13F filings for Q1 2022.